{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T21:01:47Z","timestamp":1765486907428},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,18]]},"DOI":"10.7759\/cureus.39176","type":"journal-article","created":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T11:14:18Z","timestamp":1684408458000},"source":"Crossref","is-referenced-by-count":2,"title":["Ceftriaxone-Induced Neutropenia Successfully Treated With Alternative \u03b2-Lactam Antibiotics: A Case Report and Review of the Literature"],"prefix":"10.7759","author":[{"given":"Kana","family":"Satake","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2017.1.187","article-title":"Non-chemotherapy drug-induced neutropenia: key points to manage the challenges","volume":"2017","author":"Curtis BR","year":"2017","unstructured":"Curtis BR. Non-chemotherapy drug-induced neutropenia: key points to manage the challenges. Hematology Am Soc Hematol Educ Program. 2017, 2017:187-93. 10.1182\/asheducation-2017.1.187","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2011.01321.x","article-title":"Adverse events induced by ceftriaxone: a 10-year review of reported cases to Iranian Pharmacovigilance Centre","volume":"37","author":"Shalviri G","year":"2012","unstructured":"Shalviri G, Yousefian S, Gholami K. Adverse events induced by ceftriaxone: a 10-year review of reported cases to Iranian Pharmacovigilance Centre. J Clin Pharm Ther. 2012, 37:448-51. 10.1111\/j.1365-2710.2011.01321.x","journal-title":"J Clin Pharm Ther"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy042","article-title":"Influence of reported penicillin allergy on mortality in MSSA bacteremia","volume":"5","author":"Turner NA","year":"2018","unstructured":"Turner NA, Moehring R, Sarubbi C, et al.. Influence of reported penicillin allergy on mortality in MSSA bacteremia. Open Forum Infect Dis. 2018, 5:ofy042. 10.1093\/ofid\/ofy042","journal-title":"Open Forum Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofv007","article-title":"Cephalosporin side chain idiosyncrasies: a case report of ceftriaxone-induced agranulocytosis and review of literature","volume":"2","author":"Uy N","year":"2015","unstructured":"Uy N, Thiagarajan P, Musher DM. Cephalosporin side chain idiosyncrasies: a case report of ceftriaxone-induced agranulocytosis and review of literature. Open Forum Infect Dis. 2015, 2:ofv007. 10.1093\/ofid\/ofv007","journal-title":"Open Forum Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.23226","article-title":"Ceftriaxone-induced reversible agranulocytosis: a case report and review of drug-induced agranulocytosis","volume":"14","author":"Munir F","year":"2022","unstructured":"Munir F, Javaid HW, Rana MB, Shaukat F. Ceftriaxone-induced reversible agranulocytosis: a case report and review of drug-induced agranulocytosis. Cureus. 2022, 14:e23226. 10.7759\/cureus.23226","journal-title":"Cureus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.12890\/2021_002215","article-title":"Ceftriaxone-induced agranulocytosis","volume":"8","author":"Couto L","year":"2021","unstructured":"Couto L, Goulart A, Valad\u00e3o I, Gar\u00e7a M, Santos MB, Cota P, Teixeira C. Ceftriaxone-induced agranulocytosis. Eur J Case Rep Intern Med. 2021, 8:002215. 10.12890\/2021_002215","journal-title":"Eur J Case Rep Intern Med"},{"key":"ref7","unstructured":"EUCAST. clinical breakpoints and dosing of antibiotics. (2023). Accessed: April 19, 2023: https:\/\/www.eucast.org\/clinical_breakpoints."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0b013e3282f15fb9","article-title":"Idiosyncratic drug-induced agranulocytosis or acute neutropenia","volume":"15","author":"Andr\u00e8s E","year":"2008","unstructured":"Andr\u00e8s E, Maloisel F. Idiosyncratic drug-induced agranulocytosis or acute neutropenia. Curr Opin Hematol. 2008, 15:15-21. 10.1097\/MOH.0b013e3282f15fb9","journal-title":"Curr Opin Hematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-9-200705010-00009","article-title":"Systematic review: agranulocytosis induced by nonchemotherapy drugs","volume":"146","author":"Andersohn F","year":"2007","unstructured":"Andersohn F, Konzen C, Garbe E. Systematic review: agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med. 2007, 146:657-65. 10.7326\/0003-4819-146-9-200705010-00009","journal-title":"Ann Intern Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-45. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/152.1.90","article-title":"Inhibition of granulopoiesis in vivo and in vitro by beta-lactam antibiotics","volume":"152","author":"Neftel KA","year":"1985","unstructured":"Neftel KA, Hauser SP, M\u00fcller MR. Inhibition of granulopoiesis in vivo and in vitro by beta-lactam antibiotics. J Infect Dis. 1985, 152:90-8. 10.1093\/infdis\/152.1.90","journal-title":"J Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/106002808802201024","article-title":"Ceftriaxone-associated neutropenia","volume":"22","author":"Baciewicz AM","year":"1988","unstructured":"Baciewicz AM, Skiest DJ, Weinshel EL. Ceftriaxone-associated neutropenia. Drug Intell Clin Pharm. 1988, 22:826-7. 10.1177\/106002808802201024","journal-title":"Drug Intell Clin Pharm"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1985.tb02813.x","article-title":"Drug-induced agranulocytosis: evidence for the commitment of bone marrow haematopoiesis","volume":"35","author":"Heit W","year":"1985","unstructured":"Heit W, Heimpel H, Fischer A, Frickhofen N. Drug-induced agranulocytosis: evidence for the commitment of bone marrow haematopoiesis. Scand J Haematol. 1985, 35:459-68. 10.1111\/j.1600-0609.1985.tb02813.x","journal-title":"Scand J Haematol"},{"key":"ref14","article-title":"Sulfasalazine-induced agranulocytosis","volume":"80","author":"Jacobson IM","year":"1985","unstructured":"Jacobson IM, Kelsey PB, Blyden GT, Demirjian ZN, Isselbacher KJ. Sulfasalazine-induced agranulocytosis. Am J Gastroenterol. 1985, 80:118-21.","journal-title":"Am J Gastroenterol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/BF03344959","article-title":"Antithyroid drug-induced agranulocytosis: clinical experience with ten patients treated at one institution and review of the literature","volume":"17","author":"Meyer-Gessner M","year":"1994","unstructured":"Meyer-Gessner M, Benker G, Lederbogen S, Olbricht T, Reinwein D. Antithyroid drug-induced agranulocytosis: clinical experience with ten patients treated at one institution and review of the literature. J Endocrinol Invest. 1994, 17:29-36. 10.1007\/BF03344959","journal-title":"J Endocrinol Invest"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1155\/2009\/495863","article-title":"Drug-induced hematologic syndromes","volume":"2009","author":"Mintzer DM","year":"2009","unstructured":"Mintzer DM, Billet SN, Chmielewski L. Drug-induced hematologic syndromes. Adv Hematol. 2009, 2009:495863. 10.1155\/2009\/495863","journal-title":"Adv Hematol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2017.08.027","article-title":"Cross-reactivity in \u03b2-lactam allergy","volume":"6","author":"Zagursky RJ","year":"2018","unstructured":"Zagursky RJ, Pichichero ME. Cross-reactivity in \u03b2-lactam allergy. J Allergy Clin Immunol Pract. 2018, 6:72-81. 10.1016\/j.jaip.2017.08.027","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2019.10.023","article-title":"Comparison of penicillins (penicillin G and ampicillin) and cefazolin as a definitive therapy against penicillin-susceptible Staphylococcus aureus (PSSA) bacteremia in Japan: a retrospective cohort study","volume":"26","author":"Moriyama Y","year":"2020","unstructured":"Moriyama Y, Ishikane M, Mezaki K, Ohmagari N. Comparison of penicillins (penicillin G and ampicillin) and cefazolin as a definitive therapy against penicillin-susceptible Staphylococcus aureus (PSSA) bacteremia in Japan: a retrospective cohort study. J Infect Chemother. 2020, 26:358-62. 10.1016\/j.jiac.2019.10.023","journal-title":"J Infect Chemother"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/155093-ceftriaxone-induced-neutropenia-successfully-treated-with-alternative--lactam-antibiotics-a-case-report-and-review-of-the-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:00:57Z","timestamp":1707508857000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/155093-ceftriaxone-induced-neutropenia-successfully-treated-with-alternative--lactam-antibiotics-a-case-report-and-review-of-the-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,18]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.39176","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,18]]}}}